If you have not invested in an eRegulatory solution, you most likely have a mental list of reasons why. You’re not alone. While a majority of clinical research sites now use a purpose-built platform (61% surveyed in 2020), those who do not often list reasonable barriers to adoption.
After working with over 7,200 research organizations moving to eRegulatory, we boiled down the main reasons we hear into 8 categories. All these fears appear valid at first, and 4 years ago many were, but now data shows a majority of them are no longer a reality.